In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with 18F-PBR111 PET
暂无分享,去创建一个
Richard Nicholas | Paul M. Matthews | Rexford D. Newbould | Roger N. Gunn | Qi Guo | Olga Ciccarelli | Paola Piccini | Eugenii A. Rabiner | David R. Owen | Nils Muhlert | Omar Malik | P. Matthews | O. Ciccarelli | N. Muhlert | E. Rabiner | R. Gunn | P. Piccini | A. Colasanti | O. Malik | R. Nicholas | D. Owen | R. Newbould | P. Muraro | Paolo A. Muraro | Alessandro Colasanti | Mayca Onega | P. Giannetti | Paolo Giannetti | Stuart Rison | Charlotte Thomas | Q. Guo | S. Rison | M. Ónega | C.L. Thomas | C. Thomas
[1] P. Casellas,et al. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. , 1993, Life sciences.
[2] Roger N Gunn,et al. Quantification of the Specific Translocator Protein Signal of 18F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding , 2013, The Journal of Nuclear Medicine.
[3] Massimo Filippi,et al. Association between pathological and MRI findings in multiple sclerosis , 2012, The Lancet Neurology.
[4] C. Wiley,et al. The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders , 2008, Journal of neuropathology and experimental neurology.
[5] W. Brück,et al. The spectrum of multiple sclerosis: new lessons from pathology , 2005, Current Opinion in Neurology.
[6] Ronald Boellaard,et al. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] J. Korf,et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study , 2005, Multiple sclerosis.
[8] W. M. van der Flier,et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[9] B. Trapp,et al. Pathogenesis of tissue injury in MS lesions , 1999, Journal of Neuroimmunology.
[10] J. Parratt,et al. Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions , 2009, Annals of neurology.
[11] Roger N Gunn,et al. Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] P. Mcgeer,et al. Cellular immune response in multiple sclerosis plaques. , 1990, The American journal of pathology.
[13] F. Turkheimer,et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] Hervé Boutin,et al. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[15] H. Lassmann,et al. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? , 2007, Brain : a journal of neurology.
[16] M. Grégoire,et al. Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. , 2008, Journal of medicinal chemistry.
[17] Elizabeth Fisher,et al. Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations , 2011, Annals of neurology.
[18] J Versijpt,et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 , 2003, European journal of neurology.
[19] A. Guidotti,et al. Topology of two DBI receptors in human lymphocytes. , 1993, Life sciences.
[20] D. Ingram,et al. Age and gender effects on microglia and astrocyte numbers in brains of mice , 2002, Brain Research.
[21] Alan C. Evans,et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis , 1997, Journal of neuroscience research.
[22] M. Grégoire,et al. Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing–Remitting Experimental Autoimmune Encephalomyelitis , 2013, The Journal of Nuclear Medicine.
[23] J. Merrill,et al. The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.
[24] F. Turkheimer,et al. Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study , 2014, Neurobiology of Disease.
[25] S. Gunn,et al. Positron Emission Tomography Compartmental Models , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] Roger N Gunn,et al. An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] B. Gulyás,et al. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106 , 2013, EJNMMI Research.
[28] S. Bilbo,et al. Sex differences in microglial colonization of the developing rat brain , 2012, Journal of neurochemistry.
[29] Sunhee C. Lee,et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain , 2009, Neuropathology and applied neurobiology.
[30] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] J. Geurts,et al. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation , 2012, Journal of Neuroinflammation.
[32] F Barkhof,et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.
[33] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[34] Peter A. Calabresi,et al. Decreased microglial activation in MS patients treated with glatiramer acetate , 2012, Journal of Neurology.
[35] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[36] V. Ikonomidou,et al. Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis , 2011, Journal of Neuroimmune Pharmacology.
[37] W. Brück,et al. Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons , 2013, Acta Neuropathologica.
[38] B. Gulyás,et al. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients , 2008, Journal of the Neurological Sciences.
[39] Hans Lassmann,et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.